The use of biomarkers in the elderly: current and future challenges.

Geriatric Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892, USA.
Biological Psychiatry (Impact Factor: 9.47). 09/2005; 58(4):272-6. DOI: 10.1016/j.biopsych.2005.05.016
Source: PubMed

ABSTRACT Biomarkers are hypothesized but not frequently used in research with the elderly because of a general paucity of supportive scientific data. However, there is an obvious need for greater diagnostic specificity and sensitivity across many diagnoses in the elderly, as well as good targets for therapeutic trials. The authors reviewed the available information in this field as part of a general review of geriatric research for the . Potential biomarkers with pathophysiologic significance have been studied in the field of Alzheimer disease research with some success, especially in the area of genetic markers (apolipoprotein E [APOE] epsilon4 allele), neuroimaging, and cerebrospinal fluid markers (beta-amyloid and tau). While some progress has been made in the search for adequate biomarkers in the elderly, in particular with Alzheimer disease, much more work is needed before these potential biomarkers can be reliably used in clinical practice.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Diagnosis of schizophrenia does not have a clear objective test at present, so we aimed to identify the potential biomarkers for the diagnosis of schizophrenia by comparison of serum protein profiling between first-episode schizophrenia patients and healthy controls. The combination of a magnetic bead separation system with matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry (MALDI-TOF/TOF-MS) was used to analyze the serum protein spectra of 286 first-episode patients with schizophrenia, 41 chronic disease patients and 304 healthy controls. FlexAnlysis 3.0 and ClinProTools(TM) 2.1 software was used to establish a diagnostic model for schizophrenia. The results demonstrated that 10 fragmented peptides demonstrated an optimal discriminatory performance. Among these fragmented peptides, the peptide with m/z 1206.58 was identified as a fragment of fibrinopeptide A. Receiver operating characteristic analysis for m/z 1206.58 showed that the area under the curve was 0.981 for schizophrenia vs healthy controls, and 0.999 for schizophrenia vs other chronic disease controls. From our result, we consider that the analysis of serum protein spectrum using the magnetic bead separation system and MALDI-TOF/TOF-MS is an objective diagnostic tool. We conclude that fibrinopeptide A has the potential to be a biomarker for diagnosis of schizophrenia. This protein may also help to elucidate schizophrenia disease pathogenesis. Copyright © 2013 John Wiley & Sons, Ltd.
    Biomedical Chromatography 05/2014; 28(5). DOI:10.1002/bmc.3084 · 1.95 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Data-driven machine-learning techniques enable the modeling and interpretation of complex physiological signals. The energy consumption of these techniques, however, can be excessive, due to the complexity of the models required. In this paper, we study the tradeoffs and limitations imposed by the energy consumption of high-order detection models implemented in devices designed for intelligent biomedical sensing. Based on the flexibility and efficiency needs at various processing stages in data-driven biomedical algorithms, we explore options for hardware specialization through architectures based on custom instruction and coprocessor computations. We identify the limitations in the former, and propose a coprocessor-based platform that exploits parallelism in computation as well as voltage scaling to operate at a subthreshold minimum-energy point. We present results from post-layout simulation of cardiac arrhythmia detection with patient data from the MIT-BIH database. After wavelet-based feature extraction, which consumes 12.28 μJ, we demonstrate classification computations in the 12.00-120.05 μJ range using 10000-100000 support vectors. This represents 1170× lower energy than that of a low-power processor with custom instructions alone. After morphological feature extraction, which consumes 8.65 μJ of energy, the corresponding energy numbers are 10.24-24.51 μJ, which is 1548× smaller than one based on a custom-instruction design. Results correspond to Vdd=0.4 V and a data precision of 8 b.
    IEEE Transactions on Very Large Scale Integration (VLSI) Systems 10/2013; 21(10):1849-1862. DOI:10.1109/TVLSI.2012.2220161 · 1.14 Impact Factor
  • Source